Kenneth Hoberman - Net Worth and Insider Trading
Kenneth Hoberman Net Worth
The estimated net worth of Kenneth Hoberman is at least $9 Million dollars as of 2024-12-01. Kenneth Hoberman is the COO of Stemline Therapeutics Inc and owns about 771,764 shares of Stemline Therapeutics Inc (STML) stock worth over $9 Million. Details can be seen in Kenneth Hoberman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Hoberman has not made any transactions after 2020-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Hoberman
Kenneth Hoberman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Hoberman owns 3 companies in total, including TG Therapeutics Inc (TGTX) , Stemline Therapeutics Inc (STML) , and Nuvectis Pharma Inc (NVCT) .
Click here to see the complete history of Kenneth Hoberman’s form 4 insider trades.
Insider Ownership Summary of Kenneth Hoberman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TGTX | TG Therapeutics Inc | 2020-06-22 | director |
| STML | Stemline Therapeutics Inc | 2020-06-10 | Chief Operating Officer |
| NVCT | Nuvectis Pharma Inc | 2022-02-08 | director |
Kenneth Hoberman Latest Holdings Summary
Kenneth Hoberman currently owns a total of 1 stock. Kenneth Hoberman owns 771,764 shares of Stemline Therapeutics Inc (STML) as of March 10, 2020, with a value of $9 Million.
Latest Holdings of Kenneth Hoberman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STML | Stemline Therapeutics Inc | 2020-03-10 | 771,764 | 11.83 | 9,129,968 |
Holding Weightings of Kenneth Hoberman
Kenneth Hoberman Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Hoberman has made a total of 5 transactions in Stemline Therapeutics Inc (STML) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Stemline Therapeutics Inc is the sale of 26,191 shares on March 10, 2020, which brought Kenneth Hoberman around $130,169.
Insider Trading History of Kenneth Hoberman
- 1
Kenneth Hoberman Trading Performance
Kenneth Hoberman Ownership Network
Kenneth Hoberman Owned Company Details
What does TG Therapeutics Inc do?
Who are the key executives at TG Therapeutics Inc?
Kenneth Hoberman is the director of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .
TG Therapeutics Inc (TGTX) Insider Trades Summary
Over the past 18 months, Kenneth Hoberman made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 70,787 shares made by Sagar Lonial , a net sale of 64,500 shares made by Laurence N Charney , and a net sale of 121,514 shares made by Sean A Power .
In summary, during the past 3 months, insiders sold 50,000 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 276,801 shares of TG Therapeutics Inc (TGTX) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 176,801 shares.
TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TG Therapeutics Inc Insider Transactions
Kenneth Hoberman Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Hoberman. You might contact Kenneth Hoberman via mailing address: 750 Lexington Avenue, 6th Floor, New York Ny 10024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
